Pantoprazole Sodium Hydrate

泮托拉唑钠

Report date: 2026/05/28 20:00:21

Base Information

Drug NamePantoprazole Sodium Hydrate
Drug Alias Name泮托拉唑钠水合物ZacPacPantop泮托拉唑Tecta +[44] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingAmpullary CarcinomaFasting +[23] 
Global Approved IndicationsUlcerStomach UlcerDuodenal Ulcer +[7] 
Approved Indications in ChinaStomach UlcerDuodenal UlcerEsophagitis, Peptic +[4] 
Original Approved Country/TerritoryGermany
Original Approved Date1994/01/01
Country/TerritoryBelgiumBosnia and HerzegovinaCanada +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda GmbHWyeth Pharmaceuticals IncThe University Of Texas Health Science Center At Houston +[6] 
Inactive CompaniesMedical Statistics, University Medicine Of GoettingenWyeth LlcC.H. Boehringer Sohn Ag & Co. Kg +[18] 
Active IndicationsChemotherapy-induced nausea and vomitingUlcerAcute Kidney Injury +[11] 
Inactive IndicationsAmpullary CarcinomaFastingHemorrhage +[12] 

Other Information

ATC CodeA02BC02
Related LinksWikipediaDrugBankKEGG